Babashiv Bio Technology Plant Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -73.26%
- Profit Growth -54.72%
- Ebitda -26.67%
- Net Worth -40.55%
- Total Assets -12.70%
About Babashiv Bio Technology Plant
Babashiv Bio Technology Plant Private Limited (BBTPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 January 2017 (Eight years and one month 20 days old ). Its registered office is in Etah, Uttar Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shakeesh Kumar and Subhash Chandra serve as directors at the Company.
Company Details
- Location
Etah, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999UP2017PTC088838
- Company No.
088838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Babashiv Bio Technology Plant?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shakeesh Kumar  | Director | 02-Jan-2017 | Current |
| Subhash Chandra | Director | 02-Jan-2017 | Current |
Financial Performance of Babashiv Bio Technology Plant.
Babashiv Bio Technology Plant Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 73.26% decrease. The company also saw a substantial fall in profitability, with a 54.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Babashiv Bio Technology Plant?
Unlock access to Babashiv Bio Technology Plant's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Babashiv Bio Technology Plant?
Unlock and access historical data on people associated with Babashiv Bio Technology Plant, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Babashiv Bio Technology Plant, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Babashiv Bio Technology Plant's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.